# Roka BioScience, Inc.: Form D filings

Roka BioScience, Inc., a biotechnology company in Warren, NJ, filed 6 Form D notices with the SEC between 2009 and 2016. The latest, on September 30, 2016, reports $22.5 million sold of a $22.5 million offering to 32 investors.

Find out what Roka BioScience, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Roka%20BioScience%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Roka%20BioScience%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Froka-bioscience-inc-1472343)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Roka%20BioScience%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Roka%20BioScience%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Froka-bioscience-inc-1472343)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in New Jersey](https://specstream.ai/data/form-d/state/new-jersey): 714 rows, by operating companies, filed since November 1, 2024, $35.70, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/new-jersey
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 20 INDEPENDENCE BOULEVARD, Warren, NJ, 07059
- Phone: (908) 605-4700
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1472343

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Sep 30, 2016 | New notice | $22,500,000 | $22,500,000 | $0 | 32 | Sep 21, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1472343/000090571816001680/0000905718-16-001680-index.htm) |
| Dec 5, 2013 | New notice | $16,996,657 | $16,996,657 | $0 | 5 | Nov 20, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1472343/000114036113045018/0001140361-13-045018-index.htm) |
| Jun 27, 2013 | New notice | $24,999,999 | $24,999,999 | $0 | 5 | Jun 13, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1472343/000114036113026535/0001140361-13-026535-index.htm) |
| Dec 28, 2011 | Amendment | Indefinite | $27,500,000 | Indefinite | 5 | Sep 10, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1472343/000114036111059049/0001140361-11-059049-index.htm) |
| May 17, 2011 | Amendment | $20,000,001 | $20,000,001 | $0 | 5 | Sep 10, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1472343/000114420411030537/0001144204-11-030537-index.htm) |
| Sep 23, 2009 | New notice | $49,329,524 | $29,438,587 | $19,890,937 | 6 | Sep 10, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1472343/000092963809001434/0000929638-09-001434-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Lars Boesgaard | Executive Officer |  |
| David G. McGirr | Director |  |
| Nicholas G. Valeriani | Director |  |
| Jim G. Barret, PhD | Director |  |
| Michael P. Doyle | Director |  |
| Fred G. Cohen | Director |  |
| Jonathan G. Silverstein | Director |  |
| Paul G. Thomas | Executive Officer, Director |  |

## Other biotechnology companies in New Jersey that filed recently

- [Ensho Therapeutics, Inc.](https://specstream.ai/data/form-d/company/ensho-therapeutics-inc-2032849) $7.3 million · Oct 15, 2026
- [Xenon Ophthalmics Inc](https://specstream.ai/data/form-d/company/xenon-ophthalmics-inc-1988832) $3.3 million · Oct 6, 2026
- [LISATA THERAPEUTICS, INC.](https://specstream.ai/data/form-d/company/lisata-therapeutics-inc-320017) $351.9 million · Oct 2, 2026

[Every Form D from the week of Sep 26, 2016](https://specstream.ai/data/form-d/week/2016-09-26) · [All recent filings in New Jersey](https://specstream.ai/data/form-d/state/new-jersey) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what Roka BioScience, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).